Lumicell s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
Lumicell Announces FDA Advisory Committee s Positive Recommendation on the Benefit-Risk Profile of LUMISIGHT in the Detection of Cancerous Tissue During Breast Conserving Surgery itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.
The imaging agent and visualization system will be an adjunct to standard of care to reduce residual cancer in the lumpectomy cavity during initial surgery.
Intracavity, real-time assessment of margins using a novel imaging agent and visualization system may improve complete resection rates, new findings show.